166 related articles for article (PubMed ID: 24486204)
1. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
2. Sequence specificity and role of proximal amino acids of the histone H3 tail on catalysis of murine G9A lysine 9 histone H3 methyltransferase.
Chin HG; Pradhan M; Estève PO; Patnaik D; Evans TC; Pradhan S
Biochemistry; 2005 Oct; 44(39):12998-3006. PubMed ID: 16185068
[TBL] [Abstract][Full Text] [Related]
3. Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9.
Mori S; Iwase K; Iwanami N; Tanaka Y; Kagechika H; Hirano T
Bioorg Med Chem; 2010 Dec; 18(23):8158-66. PubMed ID: 21036620
[TBL] [Abstract][Full Text] [Related]
4. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
5. IVMBIX-01294, an inhibitor of the histone methyltransferase EHMT2, disrupts histone H3 lysine 9 (H3K9) dimethylation in the cleavage-stage porcine embryo.
Park KE; Johnson CM; Cabot RA
Reprod Fertil Dev; 2012; 24(6):813-21. PubMed ID: 22781932
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
7. Label-free measurement of histone lysine methyltransferases activity by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Guitot K; Scarabelli S; Drujon T; Bolbach G; Amoura M; Burlina F; Jeltsch A; Sagan S; Guianvarc'h D
Anal Biochem; 2014 Jul; 456():25-31. PubMed ID: 24747023
[TBL] [Abstract][Full Text] [Related]
8. Amide-derived lysine analogues as substrates and inhibitors of histone lysine methyltransferases and acetyltransferases.
Hintzen JCJ; Merx J; Maas MN; Langens SGHA; White PB; Boltje TJ; Mecinović J
Org Biomol Chem; 2021 Dec; 20(1):173-181. PubMed ID: 34877957
[TBL] [Abstract][Full Text] [Related]
9. A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.
Guitot K; Drujon T; Burlina F; Sagan S; Beaupierre S; Pamlard O; Dodd RH; Guillou C; Bolbach G; Sachon E; Guianvarc'h D
Anal Bioanal Chem; 2017 Jun; 409(15):3767-3777. PubMed ID: 28389916
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the methylation site specificity of SET7/9.
Couture JF; Collazo E; Hauk G; Trievel RC
Nat Struct Mol Biol; 2006 Feb; 13(2):140-6. PubMed ID: 16415881
[TBL] [Abstract][Full Text] [Related]
11. Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase.
Dhayalan A; Kudithipudi S; Rathert P; Jeltsch A
Chem Biol; 2011 Jan; 18(1):111-20. PubMed ID: 21276944
[TBL] [Abstract][Full Text] [Related]
12. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.
Kubicek S; O'Sullivan RJ; August EM; Hickey ER; Zhang Q; Teodoro ML; Rea S; Mechtler K; Kowalski JA; Homon CA; Kelly TA; Jenuwein T
Mol Cell; 2007 Feb; 25(3):473-81. PubMed ID: 17289593
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based methods for screening writers and readers of histone methyl marks.
Allali-Hassani A; Wasney GA; Siarheyeva A; Hajian T; Arrowsmith CH; Vedadi M
J Biomol Screen; 2012 Jan; 17(1):71-84. PubMed ID: 21972038
[TBL] [Abstract][Full Text] [Related]
14. Interaction between DNA/histone methyltransferases and their inhibitors.
Hu J; Chen S; Kong X; Zhu K; Cheng S; Zheng M; Jiang H; Luo C
Curr Med Chem; 2015; 22(3):360-72. PubMed ID: 25386815
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
Krishnan S; Horowitz S; Trievel RC
Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
[TBL] [Abstract][Full Text] [Related]
16. Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
Takemoto Y; Ito A; Niwa H; Okamura M; Fujiwara T; Hirano T; Handa N; Umehara T; Sonoda T; Ogawa K; Tariq M; Nishino N; Dan S; Kagechika H; Yamori T; Yokoyama S; Yoshida M
J Med Chem; 2016 Apr; 59(8):3650-60. PubMed ID: 27088648
[TBL] [Abstract][Full Text] [Related]
17. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly.
Sampath SC; Marazzi I; Yap KL; Sampath SC; Krutchinsky AN; Mecklenbräuker I; Viale A; Rudensky E; Zhou MM; Chait BT; Tarakhovsky A
Mol Cell; 2007 Aug; 27(4):596-608. PubMed ID: 17707231
[TBL] [Abstract][Full Text] [Related]
18. Insights for the design of protein lysine methyltransferase G9a inhibitors.
Charles MRC; Dhayalan A; Hsieh HP; Coumar MS
Future Med Chem; 2019 May; 11(9):993-1014. PubMed ID: 31141392
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.
Cao H; Li L; Yang D; Zeng L; Yewei X; Yu B; Liao G; Chen J
Eur J Med Chem; 2019 Oct; 179():537-546. PubMed ID: 31276898
[TBL] [Abstract][Full Text] [Related]
20. A coupled fluorescent assay for histone methyltransferases.
Collazo E; Couture JF; Bulfer S; Trievel RC
Anal Biochem; 2005 Jul; 342(1):86-92. PubMed ID: 15958184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
